Engineered miniature CRISPR-Cas system for mammalian genome regulation and editing.
.
A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer's disease.
.
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial.